(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

SÍNTESE DE MAVORIXAFOR E INTERMEDIÁRIOS DO MESMO

ArquivadaInvention PatentPCT · US2022046094

Application data

Number

112024006701

Type

Invention Patent

Filing

10/07/2022

Publication

07/09/2024

PCT

US2022046094

Progress at the INPI

  1. Filing10/07/22
  2. Publication07/09/24
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 10/07/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 01/06/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

X4 PHARMACEUTICALS, INC.

US

Inventors

K. B. (pessoa física)

IT

R. H. (pessoa física)

US

Technical data

Priority claims

US

63/262,225 · 10/07/2021

Abstract

SÍNTESE DE MAVORIXAFOR E INTERMEDIÁRIOS DO MESMO. A presente invenção refere-se aos métodos para sintetizar o inibidor do receptor C-X-C tipo 4 (CXCR4), mavorixafor e aos intermediários do mesmo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

01/06/2026

RPI 2870

Arquivamento - Art. 33 da LPI

#11.1

10/14/2025

RPI 2858

Notificação de entrada na fase nacional - PCT

#1.3

07/09/2024

RPI 2792

Alteração de dados cadastrais

#1.1

04/16/2024

RPI 2780

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.